Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia 11Prostatic Neoplasms 10Lymphoma 9Leukemia, Monocytic, Acute 8Leukemia, Erythroblastic, Acute 8Leukemia, Myelomonocytic, Acute 7Congenital Abnormalities 7Lymphoma, Follicular 6Leukemia, Megakaryoblastic, Acute 6Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Leukemia, Biphenotypic, Acute 5Recurrence 3Sarcoma, Myeloid 2Neoplasms 2Myeloproliferative Disorders 2Lymphoma, Mantle-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Waldenstrom Macroglobulinemia 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Myeloid Malignancies 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, T-Cell 1

Interventions

Cytarabine 9Etoposide 4Daunorubicin 4Idarubicin 3Mitoxantrone 2Gemtuzumab 2Clofarabine 2Asparaginase 2tipifarnib 1temsirolimus 1palmitoyl-L-asparaginase 1midostaurin 1etoposide phosphate 1eltrombopag 1dexamethasone acetate 1alvocidib 1aldesleukin 1Whole-Body Irradiation 1Thioguanine 1Proto-Oncogene Proteins c-kit 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Observation 1Lenalidomide 1Imatinib Mesylate 1Gene Expression Profiling 1Flow Cytometry 1Filgrastim 1Busulfan 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Leukemia, Eosinophilic, Acute × Mitoxantrone × Clear all
NCT00372593 2021-03-24

Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia

Children's Oncology Group

Phase 3 Completed
1,070 enrolled 18 charts 1 FDA
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT00407966 2015-08-04

Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
45 enrolled 7 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡